558
Views
50
CrossRef citations to date
0
Altmetric
Research Article

Some new Cu(II) complexes containing O,N-donor Schiff base ligands derived from 4-aminoantipyrine: synthesis, characterization, crystal structure and substitution effect on antimicrobial activity

ORCID Icon, , , , & ORCID Icon
Pages 1534-1549 | Received 24 Sep 2020, Accepted 24 Feb 2021, Published online: 25 Mar 2021
 

Abstract

A new series of mononuclear Cu(II) complexes, [Cu(L1)2]: C1, [Cu(L2)2]: C2, [Cu(L3)2]: C3 and [Cu(L4)2]: C4, with bis-O,N-bidentate Schiff base ligands (HL1: (E)-4-[(2-hydroxy-5-bromobenzylidene)amino]-1,5-dimethyl-2-phenyl-1,2-dihydro-3H-pyrazol-3-one; HL2: (E)-4-[(2-hydroxy-5-chlorobenzylidene)amino]-1,5-dimethyl-2-phenyl-1,2-dihydro-3H-pyrazol-3-one; HL3: (E)-4-[(2-hydroxy-5-hydroxybenzylidene)amino]-1,5-dimethyl-2-phenyl-1,2-dihydro-3H-pyrazol-3-one; HL4: (E)-4-[(2-hydroxy-5-nitrobenzylidene)amino]-1,5-dimethyl-2-phenyl-1,2-dihydro-3H-pyrazol-3-one) have been prepared and characterized by elemental (CHN) analyses, FT-IR and multinuclear NMR (1H and 13C) spectroscopy. Furthermore, the crystal structures of HL3, HL4 and C4 were analyzed by single-crystal X-ray diffraction (SC-XRD). The XRD studies revealed that C4 has 2:1 ligand-to-metal ratio and adapts highly distorted square planar geometry. The in vitro antibacterial activities of the synthesized ligands and their respective copper(II) complexes were elaborated by screening them against Staphylococcus aureus and Escherichia coli. The results showed a wide range of antimicrobial activity due to different electronic environments of the substituents on phenolic moiety.

Graphical Abstract

Acknowledgements

The support of this work by Ardakan University and Payame Noor University are gratefully acknowledged. H.K. thanks Prof. Mehmet Akkurt from Erciyes University for the X-ray analysis of complex C4.

Disclosure statement

No potential conflict of interest was reported by the authors.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.